Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2021

Loading...
Loading...

 

Upgrades

  • For Sealed Air Corp SEE, Seaport Global upgraded the previous rating of Neutral to Buy. Sealed Air earned $0.89 in the fourth quarter, compared to $0.78 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.90 and a 52-week-low of $17.06. Sealed Air closed at $45.42 at the end of the last trading period.
  • For Blackbaud Inc BLKB, Benchmark upgraded the previous rating of Hold to Buy. For the fourth quarter, Blackbaud had an EPS of $0.85, compared to year-ago quarter EPS of $0.51. At the moment, the stock has a 52-week-high of $83.70 and a 52-week-low of $38.22. Blackbaud closed at $77.20 at the end of the last trading period.
  • According to Gordon Haskett, the prior rating for Nordstrom Inc JWN was changed from Hold to Buy. Nordstrom earned $0.22 in the third quarter, compared to $0.81 in the year-ago quarter. The stock has a 52-week-high of $42.22 and a 52-week-low of $11.72. At the end of the last trading period, Nordstrom closed at $34.02.
  • For Mesa Air Group Inc MESA, Deutsche Bank upgraded the previous rating of Hold to Buy. Mesa Air Group earned $0.36 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $8.64 and a 52-week-low of $2.05. At the end of the last trading period, Mesa Air Group closed at $7.44.
  • According to SVB Leerink, the prior rating for Deciphera Pharmaceuticals Inc DCPH was changed from Market Perform to Outperform. For the fourth quarter, Deciphera Pharmaceuticals had an EPS of $1.10, compared to year-ago quarter EPS of $1.31. The current stock performance of Deciphera Pharmaceuticals shows a 52-week-high of $71.11 and a 52-week-low of $33.10. Moreover, at the end of the last trading period, the closing price was at $48.32.
  • JP Morgan upgraded the previous rating for Model N Inc MODN from Underweight to Neutral. In the first quarter, Model N showed an EPS of $0.16, compared to $0.12 from the year-ago quarter. The current stock performance of Model N shows a 52-week-high of $44.56 and a 52-week-low of $15.00. Moreover, at the end of the last trading period, the closing price was at $40.62.
  • For The Hain Celestial Group Inc HAIN, Piper Sandler upgraded the previous rating of Neutral to Overweight. Hain Celestial Group earned $0.34 in the second quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.42 and a 52-week-low of $18.12. Hain Celestial Group closed at $42.34 at the end of the last trading period.

See all analyst ratings upgrades.

 

Downgrades

  • For Stoke Therapeutics Inc STOK, Wedbush downgraded the previous rating of Outperform to Neutral. In the third quarter, Stoke Therapeutics showed an EPS of $0.41, compared to $0.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $71.58 and a 52-week-low of $15.82. Stoke Therapeutics closed at $66.33 at the end of the last trading period.
  • For Masco Corp MAS, Loop Capital downgraded the previous rating of Buy to Hold. For the fourth quarter, Masco had an EPS of $0.75, compared to year-ago quarter EPS of $0.54. The current stock performance of Masco shows a 52-week-high of $60.16 and a 52-week-low of $27.04. Moreover, at the end of the last trading period, the closing price was at $56.32.
  • SVB Leerink downgraded the previous rating for Incyte Corp INCY from Market Perform to Underperform. For the fourth quarter, Incyte had an EPS of $0.93, compared to year-ago quarter EPS of $0.65. The stock has a 52-week-high of $110.36 and a 52-week-low of $62.48. At the end of the last trading period, Incyte closed at $89.46.
  • For Corvus Pharmaceuticals Inc CRVS, Mizuho downgraded the previous rating of Buy to Neutral. Corvus Pharmaceuticals earned $0.33 in the third quarter, compared to $0.37 in the year-ago quarter. The current stock performance of Corvus Pharmaceuticals shows a 52-week-high of $6.88 and a 52-week-low of $1.01. Moreover, at the end of the last trading period, the closing price was at $4.77.
  • For Chuy's Holdings Inc CHUY, Raymond James downgraded the previous rating of Outperform to Market Perform. For the third quarter, Chuy's Holdings had an EPS of $0.31, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $43.35 and a 52-week-low of $7.28. At the end of the last trading period, Chuy's Holdings closed at $40.49.
  • Morgan Stanley downgraded the previous rating for Qualys Inc QLYS from Equal-Weight to Underweight. Qualys earned No EPS Value in the fourth quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $148.84 and a 52-week-low of $63.37. Qualys closed at $129.78 at the end of the last trading period.
  • According to Morgan Stanley, the prior rating for Lithia Motors Inc LAD was changed from Equal-Weight to Underweight. Lithia Motors earned $5.46 in the fourth quarter, compared to $2.95 in the year-ago quarter. The current stock performance of Lithia Motors shows a 52-week-high of $392.60 and a 52-week-low of $55.74. Moreover, at the end of the last trading period, the closing price was at $390.85.
  • For Virgin Galactic Holdings Inc SPCE, UBS downgraded the previous rating of Buy to Neutral. In the third quarter, Virgin Galactic Hldgs showed an EPS of $0.34, compared to $0.20 from the year-ago quarter. The current stock performance of Virgin Galactic Hldgs shows a 52-week-high of $62.80 and a 52-week-low of $9.06. Moreover, at the end of the last trading period, the closing price was at $56.72.
  • According to JP Morgan, the prior rating for Akamai Technologies Inc AKAM was changed from Overweight to Neutral. In the fourth quarter, Akamai Technologies showed an EPS of $1.33, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $124.91 and a 52-week-low of $75.18. Akamai Technologies closed at $117.97 at the end of the last trading period.
  • For Leggett & Platt Inc LEG, Raymond James downgraded the previous rating of Strong Buy to Outperform. Leggett & Platt earned $0.76 in the fourth quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $46.23 and a 52-week-low of $22.03. Leggett & Platt closed at $43.02 at the end of the last trading period.

See all analyst ratings downgrades.

 

Initiations

  • With a Hold rating, Berenberg initiated coverage on Leslies Inc LESL. The price target seems to have been set at $27.00 for Leslies. Interestingly, in the first quarter, Leslies's EPS was $0.06. The current stock performance of Leslies shows a 52-week-high of $32.84 and a 52-week-low of $19.15. Moreover, at the end of the last trading period, the closing price was at $26.96.
  • With an Overweight rating, Piper Sandler initiated coverage on Catalyst Biosciences Inc CBIO. The price target seems to have been set at $15.00 for Catalyst Biosciences. For the third quarter, Catalyst Biosciences had an EPS of $0.73, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $8.94 and a 52-week-low of $3.43. Catalyst Biosciences closed at $6.63 at the end of the last trading period.
  • Wedbush initiated coverage on Playtika Holding Corp PLTK with an Outperform rating. The price target for Playtika Holding is set to $42.00. The stock has a 52-week-high of $36.06 and a 52-week-low of $28.51. At the end of the last trading period, Playtika Holding closed at $34.28.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on ALX Oncology Holdings Inc ALXO. The price target seems to have been set at $100.00 for ALX Oncology Holdings. In the third quarter, ALX Oncology Holdings earned $0.31. The stock has a 52-week-high of $117.45 and a 52-week-low of $29.06. At the end of the last trading period, ALX Oncology Holdings closed at $82.18.
  • Needham initiated coverage on Open Lending Corp LPRO with a Buy rating. The price target for Open Lending is set to $50.00. In the third quarter, Open Lending showed an EPS of $0.62, compared to $1.25 from the year-ago quarter. The current stock performance of Open Lending shows a 52-week-high of $42.56 and a 52-week-low of $12.70. Moreover, at the end of the last trading period, the closing price was at $40.74.

See all analyst ratings initiations.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...